Atheron Therapeutics, Ltd.
Clinical trials sponsored by Atheron Therapeutics, Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug ATH-097 enters first human safety trial Results expected Oct 2026 (estimated)